Testing a new platform to screen disease-modifying therapy in type 1 diabetes

• Sandra M. Lord,

  Roles Data curation, Writing – original draft

  Affiliation Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, United States of America

  https://orcid.org/0000-0003-3508-0402

  ⨯
• Henry T. Bahnson,

  Roles Data curation, Formal analysis

  Current address: DBV Technologies, Basking Ridge, NJ, United States of America

  Affiliation Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, United States of America

  ⨯
• Carla J. Greenbaum,

  Roles Conceptualization, Funding acquisition, Writing – review & editing

  Affiliation Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, United States of America

  ⨯
• David R. Liljenquist,

  Roles Supervision

  Affiliation Rocky Mountain Diabetes Center, Idaho Falls, ID, United States of America

  ⨯
• John Virostko,

  Roles Data curation, Formal analysis, Writing – review & editing

  Affiliation Dell Medical School, University of Texas at Austin, Austin, TX, United States of America

  https://orcid.org/0000-0003-3413-8801

  ⨯
• Cate Speake

  Roles Conceptualization, Formal analysis, Writing – review & editing

  * E-mail: CSpeake@benaroyaresearch.org

  Affiliation Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, United States of America

  https://orcid.org/0000-0003-1480-4272

  ⨯